Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bile Duct Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05265208
What this trial is testing

Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer

Who this might be right for
Resectable Intrahepatic Cholangiocarcinoma
Center Eugene Marquis 62
Very early researchWithdrawnNCT06284226
What this trial is testing

An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor Patients

Who this might be right for
Solid Tumors (Pancreatic Cancer, Esophageal Cancer, Gastric Cancer, Cholangiocarcinoma, Lung Cancer and Ovarian Cancer)
Beijing Kejing Biotechnology Co., Ltd.
Not applicableLooking for participantsNCT06643208
What this trial is testing

D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fujian Provincial Hospital 37
Early research (Phase 1)Looking for participantsNCT06270706
What this trial is testing

PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumor
Pliant Therapeutics, Inc. 124
Early research (Phase 1)Study completedNCT03438435
What this trial is testing

Fluorescence QRH-882260 Peptide Imaging in the Bile Duct

Who this might be right for
Cholangiocarcinoma
D. Kim Turgeon, MD 1
Not applicableUnknownNCT05681949
What this trial is testing

Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards

Who this might be right for
Hepatocellular CarcinomaFibrolamellar Hepatocellular CarcinomaCholangiocarcinoma, Perihilar+3 more
Charite University, Berlin, Germany 1,200
Testing effectiveness (Phase 2)Study completedNCT03201458
What this trial is testing

Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer

Who this might be right for
Gallbladder CarcinomaMetastatic CholangiocarcinomaStage III Intrahepatic Cholangiocarcinoma AJCC v8+2 more
National Cancer Institute (NCI) 86
Testing effectiveness (Phase 2)Temporarily pausedNCT06050252
What this trial is testing

Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery

Who this might be right for
Resectable Intrahepatic Cholangiocarcinoma
National Cancer Institute (NCI) 27
Not applicableLooking for participantsNCT06971848
What this trial is testing

Evaluation of Skin Tests in Biotherapy Allergies

Who this might be right for
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckMelanoma NeoplasmsSmall Cell Bronchial Carcinomas+13 more
University Hospital, Angers 70
Not applicableLooking for participantsNCT06462742
What this trial is testing

Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma

Who this might be right for
Overall SurvivalDisease-free Survival
Chinese PLA General Hospital 1,000
Testing effectiveness (Phase 2)WithdrawnNCT04895046
What this trial is testing

Maintenance Niraparib and Dostarlimab in Advanced Cholangiocarcinoma

Who this might be right for
HRDCholangiocarcinomaMetastatic Cancer
Walid Shaib, MD
Testing effectiveness (Phase 2)Study completedNCT01206049
What this trial is testing

Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations

Who this might be right for
Cholangiocarcinoma
Vejle Hospital 88
Early research (Phase 1)Study completedNCT04672434
What this trial is testing

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 48
Not applicableUnknownNCT02659852
What this trial is testing

Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction

Who this might be right for
CholangiocarcinomaGallbladder CancerPancreatic Cancer+2 more
Yonsei University 70
Not applicableLooking for participantsNCT07007832
What this trial is testing

Bile Omics for Diagnosing Indeterminate Biliary Strictures

Who this might be right for
CholangiocarcinomaGallbladder Cancer and Extrahepatic CholangiocarcinomaPancreatic Cancer+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 260
Early research (Phase 1)Active Not RecruitingNCT03872947
What this trial is testing

TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorColorectal CancerCholangiocarcinoma+9 more
Toray Industries, Inc 138
Early research (Phase 1)Active Not RecruitingNCT05277766
What this trial is testing

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+5 more
University Hospital, Ghent 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT03801083
What this trial is testing

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers

Who this might be right for
Biliary Tract CancerCholangiocarcinomaBiliary Tract Neoplasms
Udai Kammula 4
Not applicableStudy completedNCT05028439
What this trial is testing

RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
First People's Hospital of Hangzhou 70
Testing effectiveness (Phase 2)Study completedNCT02273739
What this trial is testing

Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation

Who this might be right for
Solid TumorGliomaAngioimmunoblastic T-cell Lymphoma+2 more
Celgene 21
Next Page